Fehér E, Kovács A, Gallatz K, Fehér J
Department of Anatomy, Histology and Embryology, Semmelweis University Medical School, Budapest, Hungary.
Neuroimmunomodulation. 1997 Sep-Dec;4(5-6):250-7. doi: 10.1159/000097344.
Different neuropeptide-containing nerve fibers were investigated to clarify their role in the pathogenesis of Crohn's disease (CD) using immunohisto- and immunocytochemical techniques. Specimens were obtained from patients with CD from grossly affected colonic regions, from biopsies obtained from patients with CD treated with mesalazine and from control individuals. Quantitative analysis was made for the changes of the number of nerve terminals and their vesicle contents. The distribution pattern of all immunoreactive (IR) nerve fibers was similar both in the control and in the surgical specimens as well as in the biopsies obtained. The number of the synapses, the IR nerve fibers and their vesicle content were markedly decreased in the grossly affected colonic regions. Some degenerated axons were found in close proximity to the plasma cells. Immunocytochemistry demonstrated that substance P, vasoactive intestinal polypeptide and somatostatin IR nerve fibers were in direct contact with the plasma cells, lymphocytes and other immunocompetent cells. The gap between the membranes of immunoreactive nerve terminals and immunocompetent cells was 20-200 nm, in a few cases even less. In the mesalazine-treated group the number of the IR nerve terminals as well as their vesicle content was increased. These results suggest that changes in the number of different neuropeptide-containing nerve terminals and their content might alter the neuroimmunological processes, because these peptides are known to be immunoregulators.
采用免疫组织化学和免疫细胞化学技术,对不同的含神经肽神经纤维进行研究,以阐明它们在克罗恩病(CD)发病机制中的作用。标本取自CD患者病变严重的结肠区域、接受美沙拉嗪治疗的CD患者的活检组织以及对照个体。对神经末梢数量及其囊泡内容物的变化进行了定量分析。在对照、手术标本以及所取活检组织中,所有免疫反应性(IR)神经纤维的分布模式均相似。在病变严重的结肠区域,突触、IR神经纤维及其囊泡内容物的数量明显减少。在浆细胞附近发现了一些变性轴突。免疫细胞化学显示,P物质、血管活性肠肽和生长抑素IR神经纤维与浆细胞、淋巴细胞及其他免疫活性细胞直接接触。免疫反应性神经末梢与免疫活性细胞之间的膜间隙为20 - 200纳米,少数情况下甚至更小。在美沙拉嗪治疗组中,IR神经末梢数量及其囊泡内容物增加。这些结果表明,不同含神经肽神经末梢数量及其内容物的变化可能会改变神经免疫过程,因为这些肽已知是免疫调节因子。